Additional file 3: Figure S3.

During imatinib mesylate treatment, there were no differences in histological findings of the intestine, spleen, liver, and lungs between the treatment group and the control group.

Format: PPTX Size: 1.7MB Download file

Ohishi et al. BMC Cancer 2013 13:224   doi:10.1186/1471-2407-13-224